The non-stop drama of the Trump Administration makes it hard to appreciate some truly astonishing moments.
For FDA-watchers, one of those moments came Jan. 25, during the World Economic Forum in Davos, when President Donald Trump...
US FDA Commissioner A 'Star' At Davos: Hopefully Not A Bad Omen
Listen to this article
President Trump singles out Scott Gottlieb during dinner meeting at World Economic Forum. Does that make anyone else nervous?
Learn what's happening at the US FDA. On the go.
More from US FDA
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
- • By
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
- • By
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
More from Agency Leadership
- • By
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
- • By
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
